Vienna Lo Novartis

Ms. Lo has been with Novartis since 2013 in the Cell & Gene Technical Development & Manufacturing, Analytical & Process Science unit, responsible for the process development of commercial and pipeline projects.

Today, Ms. Lo manages the media project that is responsible for serum replacement, media alternative, media collaboration, as well as optimize the T-cell expansion using the AMBR 250 automated bioreactor system.